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developed countries. In the 2011 WHO report on the global burden of HAI from LMICs, SSI was the most frequent HAIs reported hospital-wide, with the level of risk being much higher than in developed countries. In this report, the pooled SSI incidence in LMICs and developed countries were, respectively, 11.8 and 5.6/100 surgical procedures. The rates of SSIs have ranged from 2.1 in the Republic of Korea to 2.5%-15.4% in Uruguay, and 1.9%-3.1% in Chile. The overall prevalence of SSI in Africa/Middle East, Latin America, Asia and China was reported to be 10%, 7%, 4% and 4%, respectively. In a review published in 2019 by Couto et al., the overall prevalence of SSI in developing countries in elective clean and clean-contaminated surgeries was estimated to be 6%, increasing to 15% when studies only focusing on post-discharge surveillance were included. [4, [10] [11] [12] [13] [14] [15] [16] surveIllance for surgIcal sIte InfectIons
In most countries, the burden of HAIs is grossly underestimated for want of proper surveillance and reporting systems. Estimation of the national burden of HAIs is a prerequisite for planning infection control policies. Robust evidence emphasises the fact that HAI can be prevented, and the burden is reduced by as much as 50%. [17] [18] [19] [20] Surveillance is defined as "the ongoing, systematic collection, analysis and interpretation of health data essential to the planning, implementation and evaluation of public health practice, closely integrated with the timely dissemination of these data to those who need to know." Surveillance of SSI is part of the WHO safe surgery guidelines. Many countries have introduced mandatory surveillance of SSI, such as the UK and certain states in the USA, whereas other countries have voluntary-based surveillance, such as France, Germany and Switzerland. [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] There is a lack of national surveillance systems in most LMIC, which is a major lacuna in planning preventing protocols and allocating resources to the highpriority areas. Therefore, there is an urgent need: • To establish reliable systems for HAI surveillance • To gather data on the actual burden of HAIs regularly • To use this data for developing indigenous preventive measures, tailored to the country's priorities.
Evaluation of the key determinants of SSIs (or risk factors) is also an essential step to identify strategies and measures for improvement.
Surveillance of SSIs is very different from other HAIs such as ventilator-associated pneumonia (VAP), central line-associated bloodstream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs). The primary difference being that surveillance for VAP, CLABSI and CAUTI are truncated at the time of discharge from the unit/hospital. In contrast, most SSIs develop after the patient is discharged from the hospital, considering the ever-shortening in-hospital stay after surgeries. Some SSIs may develop as long as 3 months or even a year after the surgery. SSI surveillance, therefore, requires a very prolonged follow-up, a lot more engagement by the patients and health-care workers, and therefore, not feasible in many LMICs. [17] [18] [19] 37, 38] Surveillance is an essential tool to reduce its burden. It is also an important first step in identifying problems and priorities; and it plays an important role in recognising risk factors for SSI thus, helping to target modifiable risk factors.
Carefully obtained surveillance data can identify needed infection prevention and control (IPC) interventions and areas of opportunity for improvements in care. The surveillance data can also help assess the quality of infection prevention efforts. Both process measures (for example, the implementation of preventive measures) and outcome measures (SSI rates) should be measured through surveillance so that IPC measures can be implemented, and performance improved. The application of standardised definitions is one of the minimum requirements for data comparisons at local, national and international levels. The use of standardised definitions is crucial to the reliability of SSI surveillance for the following reasons:
• It allows establishing that the infection was acquired during the hospital stay • To ensure that it is a true infection and not colonisation • Allows for inter-hospital comparisons and benchmarking.
The National Healthcare Safety Network (NHSN) provides the most reliable and updated definitions. [1, 39, 40] At the All India Institute of Medical Sciences, New Delhi, we have initiated a multi-centric study, supported by ICMR, where 90-day post-discharge Table 1 
: Burden of surgical site infections in developed nations
Country and year of study
Type of surveillance network/ number of hospitals

Rate of SSI (%)
Estimated additional cost of treatment/other implications due to SSI in the country
USA, 2014 [10] [11] NHSN 3654 hospitals 0.86 US $3.5 billion-10 billion Additional LOS 9.7 days per SSI European countries, 2010-2011 [12] [13] European CDC 0.75-9.5 1.4-19.1 billion euros Additional LOS 6.5 days, with three times increased cost of treatment of infected patients Australia, 2002-2013 [14] National HAI surveillance network 2.8 Japan, 2013 [4, 15] National Nosocomial Infection Surveillance system
(GI surgery)
Additional $8791 per SSI case. Additional LOS 20.7 days, may extend to 48.9 days in cardiac surgeries Singapore, 2008
Tertiary care hospital study 8.3 SSI: Surgical site infection, NHSN: National Healthcare Safety Network, CDC: Centers for Disease Control and Prevention, HAI: Healthcare-associated infection, LOS: Length of stay, GI: Gastro-intestinal surveillance is being conducted to ascertain the actual prevalence of SSI in a select group of surgeries. This manuscript describes the process of the establishment of an SSI surveillance protocol.
Objectives of a surveillance program
• Collection of data on SSI rates to ascertain the magnitude of the problem • Analysis of the data to identify and investigate trends • Ascertain the most common pathogens and their susceptibility patterns • Identify the risk factors in the Indian set-up • Interpretation of analysed data at regular intervals to provide feedback • Data-driven improvement actions • Evaluation of preventive interventions • The following are the essential prerequisites for developing a surveillance system for SSIs [1, [41] [42] [43] • An standard operating procedure (SOP) with objectives, methodology and all elements of the surveillance process • Adequate human resources for surveillance (infection control nurses and epidemiologists) • Training of all surveillance staff (induction and at regular intervals) • Consistent application of definitions and common methodology • IT/Informatic services (to design an interpret reports) • Data quality/evaluation methods • Development of a feedback mechanism • Use surveillance findings in developing/implementing preventive activities • Each hospital to use its data for internal benchmarking and setting targets.
The SSI surveillance programme should measure both infection rates and compliance rates with surgical infection prevention processes.
process and outcome measures
SSI surveillance should include measures of processes to indicate whether caregivers are adhering to best practices and established policies as well as the outcomes of care during the pre-operative, intra-operative and post-operative phases.
Process measures
In the pre-operative phase, hand hygiene, accurate assessment of patient status and risk factors, and initiating specific procedures such as maintaining normothermia, are some of the IPC processes. In the intra-operative stage, IPC processes include skin antisepsis, maintaining normothermia and glucose monitoring. Postoperatively, aseptic wound care is a primary prevention process. [44] [45] [46] [47] [48] [49] 
Calculation of compliance
All calculations can be performed by using the formula of:
The number of events (numerator) divided by the number of persons at risk or number of expected processes.
Outcome measures Monitoring/surveillance for surgical site infection
For surveillance purposes, SSIs are divided into categories involving only skin and subcutaneous tissue (superficial incisional SSIs), those involving deeper soft tissues of the incision (deep incisional SSIs), and those involving any part of the deep anatomy (organ space SSIs), such as a joint space.
The definitions for SSIs have been adopted from the Centres for Disease Control and Prevention NHSN system. [50] [51] [52] Table 2 details the classification of SSI.
We have developed a website for SSI surveillance, where the SOP is available. Definitions of SSI surveillance, wound classification and the details of surveillance methodology can be accessed at http://ssi.haisindia.com. Figure 1 shows a screenshot of the home page of the website.
Case finding
This requires active, patient-based, prospective surveillance. Both in-hospital and post-discharge surveillance methods should be used to detect SSIs. Review methods may include one or more of the following: [50] [51] [52] • Direct inspection of the wound • Medical records/surgical/OT notes/physician's notes/ admission, readmission, ED notes • Laboratory/X-ray, other diagnostic test reports • Information from the patients and families • Surveys by mail or telephone.
Role of the Hospital Infection Control Nurses (HICNs) (HICNs)/infection preventionists/epidemiologist/information technology departments (if available)
• To lead the development of the SSI surveillance plan • To perform the surveillance using established, approved, and consistent surveillance criteria or definitions • Analyse and present the data to all stakeholders.
Data collection
Collect SSI (numerator) and operative procedure category (denominator) data on all procedures included in the selected procedure categories for at least 1 month. The numerator and denominator data forms are available on the website http://ssi.haisindia.com. The surgical procedure must meet the definition of an operative procedure to be included in the surveillance. All procedures should be followed for superficial, deep and organ/space SSIs. All patients undergoing the defined surgeries (for which a hospital intends to undertake SSI surveillance) need to be monitored for SSI. SSI form should be completed for each SSI. The SSI form includes patient demographic information and information about the operative procedure, including the date and type of procedure. Information about the SSI includes the date of SSI, specific criteria met for identifying the SSI when/how the SSI was detected, whether the patient developed a secondary bloodstream infection, whether the patient died, the organism(s) identified and the organisms' antimicrobial susceptibilities. [50] [51] [52] 
calculatIon of surgIcal sIte InfectIon rates
The most common outcome indicator is the SSI rate. For any given period, denominator data represent the total number of procedures within each category. Numerator data will be the number of SSIs in that same period. SSI rates per 100 operative procedures are calculated by dividing the number of SSIs by the number of specific operative procedures and multiplying the results by 100. SSIs should be included in the numerator of a rate based on the date of procedure, not the date of the event. [50] [51] [52] Figures 2 and 3 show the SSI surveillance case report form and denominator form, respectively. The forms can be accessed at the website http://ssi.haisindia.com.
Additional terms
1. Date of event (DOE): For an SSI, the DOE is the date when the first element used to meet the SSI infection criterion occurs for the first time during the SSI surveillance period. The date of the event must fall within the SSI surveillance period to meet SSI criteria. The type of SSI (superficial incisional, deep incisional or organ/space) reported should reflect the deepest tissue layer involved in the infection during the surveillance period. The date of the event should be the date that the patient met the criteria for the deepest level of infection 2. Duration of operative procedure: The interval in hours and minutes between the procedure/surgery start time (PST), and the procedure/surgery finish (PF) time, as defined by the Association of Anaesthesia Clinical Directors • PST: Time when the procedure is begun (e.g., incision for a surgical procedure) • PF: Time, when all instrument and sponge counts are completed and verified as correct, all post-operative radiologic studies to be done in the Operating room 
Superficial incisional SSI
This is based on the following criteria: DOE for infection occurs within 30 days after a surgical procedure (where day 1 = the procedure date) and involves only skin and subcutaneous tissue of the incision and patient has at least one of the followings: a. Purulent drainage from the superficial incision b. Organisms identified from an aseptically-obtained specimen from the superficial incision or subcutaneous tissue by a culture c. Superficial incision that is deliberately opened by a surgeon and patient has at least one of the following signs or symptoms: Pain or tenderness; localised swelling; erythema or heat d. Diagnosis of a superficial incisional SSI by the surgeon/attending physician There are two specific types of superficial incisional SSIs:
1. SIP -A superficial incisional SSI that is identified in the primary incision in a patient that has had an operation with one or more incisions 2. SIS -A superficial incisional SSI that is identified in the secondary incision in a patient that has had an operation with more than one incision Deep incisional SSI This is based on the following criteria:
The DOE for infection occurs within 30 or 90 days after the operative procedure (where day 1 = the procedure date) and Involves deep soft tissues of the incision (for example, fascial and muscle layers) and patient has at least one of the following: a. Purulent drainage from the deep incision b. A deep incision that spontaneously dehisces, or is deliberately opened/aspirated by a surgeon/attending physician and organism is identified by culture and patient has at least one of the following signs or symptoms: Fever (>38°C); localised pain or tenderness. A culture-based test that has a negative finding does not meet this criterion There are two specific types of deep incisional SSIs:
1. DIP -A deep incisional SSI that is identified in a primary incision in a patient that has had an operation with one or more incisions 2. DIS -A deep incisional SSI that is identified in the secondary incision in a patient that has had an operation with more than one incision Organ/space SSI This is based on the following criteria: DOE for infection occurs within 30 or 90 days after the operative procedure and infection involves any part of the body deeper than the fascial/muscle layers, that is opened or manipulated during the operative procedure and patient has at least one of the following: a. Purulent drainage from a drain that is placed into the organ/ Wounds with non-primary closure may or may not be described as 'packed' with gauze or other material, and may or may not be covered with plastic, 'wound vacs', or other synthetic devices or materials 7. Primary closure: Closure of the skin level during the original surgery, regardless of the presence of wires, wicks, drains or other devices or objects extruding through the incision. This category includes surgeries where the skin is closed by some means.
If a procedure has multiple incision/laparoscopic trocar sites and any of the incisions are closed primarily then the procedure technique is recorded as primary closed.
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